Asset Details
Do you wish to reserve the book?
Neonatal sepsis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neonatal sepsis
Do you wish to request the book?
Neonatal sepsis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Neonatal sepsis
2017
Overview
Neonatal sepsis is the cause of substantial morbidity and mortality. Precise estimates of neonatal sepsis burden vary by setting. Differing estimates of disease burden have been reported from high-income countries compared with reports from low-income and middle-income countries. The clinical manifestations range from subclinical infection to severe manifestations of focal or systemic disease. The source of the pathogen might be attributed to an in-utero infection, acquisition from maternal flora, or postnatal acquisition from the hospital or community. The timing of exposure, inoculum size, immune status of the infant, and virulence of the causative agent influence the clinical expression of neonatal sepsis. Immunological immaturity of the neonate might result in an impaired response to infectious agents. This is especially evident in premature infants whose prolonged stays in hospital and need for invasive procedures place them at increased risk for hospital-acquired infections. Clinically, there is often little difference between sepsis that is caused by an identified pathogen and sepsis that is caused by an unknown pathogen. Culture-independent diagnostics, the use of sepsis prediction scores, judicious antimicrobial use, and the development of preventive measures including maternal vaccines are ongoing efforts designed to reduce the burden of neonatal sepsis.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Anti-Infective Agents - therapeutic use
/ Bacteria
/ Cross Infection - complications
/ Cross Infection - drug therapy
/ Female
/ Flora
/ Free Radical Scavengers - therapeutic use
/ Glucose
/ Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use
/ Humans
/ Immunoglobulins, Intravenous - therapeutic use
/ Income
/ Infants
/ Inoculum
/ Neonatal Sepsis - epidemiology
/ Neonates
/ Pentoxifylline - therapeutic use
/ Prenatal Exposure Delayed Effects
/ Sepsis
/ Vaccines
